Adding stem cells to standard Alzheimer's treatment

This trial is testing whether adding a single infusion of human mesenchymal stem cells to your existing Alzheimer's treatment can help slow down memory loss and cognitive decline. You would receive this infusion as an add-on to the medication you're already taking—either Leqembi or Kisunla—which are FDA-approved drugs for early Alzheimer's disease. The study wants to see if combining these two approaches works better than the medication alone.

Current Alzheimer's medications like Leqembi and Kisunla show promise, but they can only slow decline—not stop it or reverse it. This trial explores whether stem cells, which have special healing and anti-inflammatory properties, might enhance what these medications can do when given together.